ArticleAnnals of medicine2026

A single-center retrospective study suggests a potential benefit of BTK inhibitor-based therapy in patients with histologic transformation of Waldenström macroglobulinemia.

Yi Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.